← Leaderboards
Dennis A Carson
University Of California San Diego
$36,140,483
Attributed
$36,357,483
Total exposure
30
Grants
22
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $16.4M · FY2005–22$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$78,550,002 · 32
By mechanism
P30$62,884,037 · 20
N01$4,707,516 · 1
U01$4,341,977 · 1
P50$4,024,371 · 2
R21$1,042,000 · 2
R01$890,854 · 1
Top collaborators
- Nikunj Shukla2 shared
Most similar at University Of California San Diego
Same institution · by research overlap
- James R Feramisco$4,540,784
- Cheryl L Rock$9,282,089
- Carlos J Carrera$938,384
- William Wachsman$5,137,513
Others in their field
Top investigators on “Cancer Center”
- Leonard Freedman · Leidos Biomedical Research, Inc.$885,275,552
- David Heimbrook · Leidos Biomedical Research, Inc.$793,360,762
- Larry Arthur$473,862,081
- Richard A Gibbs · Baylor College Of Medicine$257,275,004
- Lynn Briscoe · Leidos Biomedical Research, Inc.$248,567,868
- Norman Wolmark · Nsabp Foundation, Inc.$237,419,252
Research focus
Cancer CenterResearch PersonnelResourcesMemberCancer Center Support GrantResource SharingServicesProgramsDesignFundingBaseTrainingReportingLaboratoriesAnticancer ResearchClinical ResearchMalignant NeoplasmsProtocols DocumentationConsultationsMissionHuman ResourcesTechnologyGrantClinical Trials
Grant awards (148)
Tetrahydrothieno[2,3-c]pyridines as Vaccine Co-adjuvants$197,500
R21 · FY2022 · AI
Tetrahydrothieno[2,3-c]pyridines as Vaccine Co-adjuvants$236,500
R21 · FY2021 · AI
DATA COMPILATION$725,058
P30 · FY2012 · CA · contact PI
DATA COMPILATION$200,699
P30 · FY2012 · CA · contact PI
CLINICAL TRIALS$507,382
P30 · FY2011 · CA · contact PI
TRANSGENIC MOUSE$491,282
P30 · FY2011 · CA · contact PI
MICROARRAY$481,568
P30 · FY2011 · CA · contact PI
BIOSTATISTICS$441,955
P30 · FY2011 · CA · contact PI
PROTOCOL SPECIFIC RESEARCH$415,179
P30 · FY2011 · CA · contact PI
DATA COMPILATION$380,131
P30 · FY2011 · CA · contact PI
MICROSCOPY$353,284
P30 · FY2011 · CA · contact PI
FLOW CYTROMETRY$310,901
P30 · FY2011 · CA · contact PI
NUTRITION$270,174
P30 · FY2011 · CA · contact PI
DNA SEQUENCING$259,671
P30 · FY2011 · CA · contact PI
HISTOLOGY$252,837
P30 · FY2011 · CA · contact PI
BEHAVIORAL MEASUREMENT$199,911
P30 · FY2011 · CA · contact PI
PRMS$178,501
P30 · FY2011 · CA · contact PI
Specialized Cancer Center Support Grant$4,505,660
P30 · FY2010 · CA · contact PI
CLINICAL TRIALS$548,500
P30 · FY2010 · CA · contact PI
TRANSGENIC MOUSE$531,100
P30 · FY2010 · CA · contact PI
MICROARRAY$520,596
P30 · FY2010 · CA · contact PI
BIOSTATISTICS$477,768
P30 · FY2010 · CA · contact PI
PROTOCOL SPECIFIC RESEARCH$448,828
P30 · FY2010 · CA · contact PI
DATA COMPILATION$410,937
P30 · FY2010 · CA · contact PI
MICROSCOPY$381,915
P30 · FY2010 · CA · contact PI
FLOW CYTROMETRY$336,097
P30 · FY2010 · CA · contact PI
NUTRITION$292,068
P30 · FY2010 · CA · contact PI
DNA SEQUENCING$280,714
P30 · FY2010 · CA · contact PI
HISTOLOGY$273,330
P30 · FY2010 · CA · contact PI
BEHAVIORAL MEASUREMENT$216,111
P30 · FY2010 · CA · contact PI
PRMS$192,968
P30 · FY2010 · CA · contact PI
Specialized Cancer Center Support Grant$115,875
P30 · FY2010 · CA · contact PI
Specialized Cancer Center Support Grant$100,000
P30 · FY2010 · CA · contact PI
Specialized Cancer Center Support Grant$100,000
P30 · FY2010 · CA · contact PI
Specialized Cancer Center Support Grant$50,000
P30 · FY2010 · CA · contact PI
Specialized Cancer Center Support Grant$39,397
P30 · FY2010 · CA · contact PI
Small molecule stimulators of innate immune receptors$4,707,516
N01 · FY2009 · AI · contact PI
Specialized Cancer Center Support Grant$4,005,660
P30 · FY2009 · CA · contact PI
Specialized Cancer Center Support Grant$1,519,725
P30 · FY2009 · CA · contact PI
CLINICAL TRIALS$550,646
P30 · FY2009 · CA · contact PI
TRANSGENIC MOUSE$533,177
P30 · FY2009 · CA · contact PI
MICROARRAY$522,634
P30 · FY2009 · CA · contact PI
BIOSTATISTICS$479,641
P30 · FY2009 · CA · contact PI
PROTOCOL SPECIFIC RESEARCH$450,579
P30 · FY2009 · CA · contact PI
DATA COMPILATION$412,545
P30 · FY2009 · CA · contact PI
MICROSCOPY$383,407
P30 · FY2009 · CA · contact PI
FLOW CYTROMETRY$337,408
P30 · FY2009 · CA · contact PI
NUTRITION$293,208
P30 · FY2009 · CA · contact PI
DNA SEQUENCING$281,808
P30 · FY2009 · CA · contact PI
HISTOLOGY$274,394
P30 · FY2009 · CA · contact PI
Antagonists of the Beta- Catenin Signaling Pathway$271,664
U19 · FY2009 · CA · contact PI
Specialized Cancer Center Support Grant$250,000
P30 · FY2009 · CA · contact PI
Specialized Cancer Center Support Grant$250,000
P30 · FY2009 · CA · contact PI
BEHAVIORAL MEASUREMENT$216,950
P30 · FY2009 · CA · contact PI
PRMS$193,713
P30 · FY2009 · CA · contact PI
Specialized Cancer Center Support Grant$115,875
P30 · FY2009 · CA · contact PI
Specialized Cancer Center Support Grant$115,875
P30 · FY2009 · CA · contact PI
Specialized Cancer Center Support Grant$100,000
P30 · FY2009 · CA · contact PI
Specialized Cancer Center Support Grant$92,700
P30 · FY2009 · CA · contact PI
Specialized Cancer Center Support Grant$4,005,660
P30 · FY2008 · CA · contact PI
CLINICAL TRIALS$506,835
P30 · FY2008 · CA · contact PI
TRANSGENIC MOUSE$490,757
P30 · FY2008 · CA · contact PI
MICROARRAY$481,052
P30 · FY2008 · CA · contact PI
BIOSTATISTICS$441,480
P30 · FY2008 · CA · contact PI
PROTOCOL SPECIFIC RESEARCH$414,731
P30 · FY2008 · CA · contact PI
DATA COMPILATION$379,725
P30 · FY2008 · CA · contact PI
MICROSCOPY$352,905
P30 · FY2008 · CA · contact PI
FLOW CYTROMETRY$310,568
P30 · FY2008 · CA · contact PI
NUTRITION$269,888
P30 · FY2008 · CA · contact PI
DNA SEQUENCING$259,394
P30 · FY2008 · CA · contact PI
HISTOLOGY$252,569
P30 · FY2008 · CA · contact PI
Specialized Cancer Center Support Grant$247,200
P30 · FY2008 · CA · contact PI
BEHAVIORAL MEASUREMENT$199,700
P30 · FY2008 · CA · contact PI
Antagonists of the E- Catenin Signaling Pathway$187,298
U19 · FY2008 · CA · contact PI
PRMS$178,309
P30 · FY2008 · CA · contact PI
Specialized Cancer Center Support Grant$115,875
P30 · FY2008 · CA · contact PI
Specialized Cancer Center Support Grant$92,700
P30 · FY2008 · CA · contact PI
Specialized Cancer Center Support Grant$76,478
P30 · FY2008 · CA · contact PI
Specialized Cancer Center Support Grant$3,966,000
P30 · FY2007 · CA · contact PI
OPTIMIZED SYNTHETIC TLR LIGANDS FOR BIODEFENSE$934,219
U01 · FY2007 · AI · contact PI
DEVELOPMENT$578,383
P30 · FY2007 · CA · contact PI
ADMINISTRATION$517,828
P30 · FY2007 · CA · contact PI
SR. LEADERS$346,606
P30 · FY2007 · CA · contact PI
CLINICAL TRIALS$265,494
P30 · FY2007 · CA · contact PI
TRANSGENIC MOUSE$257,070
P30 · FY2007 · CA · contact PI
MICROARRAY$251,987
P30 · FY2007 · CA · contact PI
BIOSTATISTICS$231,258
P30 · FY2007 · CA · contact PI
PROTOCOL SPECIFIC RESEARCH$217,245
P30 · FY2007 · CA · contact PI
DATA COMPILATION$198,908
P30 · FY2007 · CA · contact PI
MICROSCOPY$184,858
P30 · FY2007 · CA · contact PI
PROGRAM LEADERS$174,511
P30 · FY2007 · CA · contact PI
FLOW CYTROMETRY$162,679
P30 · FY2007 · CA · contact PI
NUTRITION$141,365
P30 · FY2007 · CA · contact PI
DNA SEQUENCING$135,870
P30 · FY2007 · CA · contact PI
HISTOLOGY$132,297
P30 · FY2007 · CA · contact PI
Specialized Cancer Center Support Grant$115,875
P30 · FY2007 · CA · contact PI
BEHAVIORAL MEASUREMENT$104,597
P30 · FY2007 · CA · contact PI
STAFF INVESTIGATORS$99,718
P30 · FY2007 · CA · contact PI
PRMS$93,391
P30 · FY2007 · CA · contact PI
Specialized Cancer Center Support Grant$92,700
P30 · FY2007 · CA · contact PI
PLANNING AND EVALUATION$80,510
P30 · FY2007 · CA · contact PI
Specialized Cancer Center Support Grant (CCSG)$3,965,858
P30 · FY2006 · CA · contact PI
OPTIMIZED SYNTHETIC TLR LIGANDS FOR BIODEFENSE$939,748
U01 · FY2006 · AI · contact PI
Specialized Cancer Center Support Grant (CCSG)$107,324
P30 · FY2006 · CA · contact PI
Specialized Cancer Center Support Grant (CCSG)$6,443,983
P30 · FY2005 · CA
OPTIMIZED SYNTHETIC TLR LIGANDS FOR BIODEFENSE$938,714
U01 · FY2005 · AI
MUCOSAL IMMUNOSTIMULANTS FOR BIODEFENSE$304,000
R21 · FY2005 · AI
Specialized Cancer Center Support Grant (CCSG)$114,000
P30 · FY2005 · CA
Specialized Cancer Center Support Grant (CCSG)$4,065,117
P30 · FY2004 · CA
OPTIMIZED SYNTHETIC TLR LIGANDS FOR BIODEFENSE$914,900
U01 · FY2004 · AI
MUCOSAL IMMUNOSTIMULANTS FOR BIODEFENSE$304,000
R21 · FY2004 · AI
Specialized Cancer Center Support Grant (CCSG)$114,000
P30 · FY2004 · CA
REGULATION OF SENESCENCE AND APOPTOSIS IN LYMPHOCYTES$89,174
R01 · FY2004 · GM
Specialized Cancer Center Support Grant (CCSG)$3,887,237
P30 · FY2003 · CA
OPTIMIZED SYNTHETIC TLR LIGANDS FOR BIODEFENSE$614,396
U01 · FY2003 · AI
Specialized Cancer Center Support Grant (CCSG)$91,200
P30 · FY2003 · CA
MOLECULAR THERAPEUTICS OF RHEUMATOID ARTHRITIS$1,107,400
P50 · FY2002 · AR
REGULATION OF SENESCENCE AND APOPTOSIS IN LYMPHOCYTES$267,520
R01 · FY2002 · GM
ROLE OF IMMUNOSTIMULATORY (ISS) DNA IN RHEUMATOID ARTHRITIS$150,001
P50 · FY2002 · AR
PILOT STUDY TO TEST EFFECTIVENESS OF ETODOLAC IN CLL$0
M01 · FY2002 · RR
PILOT STUDY TO TEST EFFECTIVENESS OF ETODOLAC IN CLL$0
M01 · FY2002 · RR
PILOT STUDY TO TEST EFFECTIVENESS OF ETODOLAC IN CLL$0
M01 · FY2002 · RR
PILOT STUDY TO TEST EFFECTIVENESS OF ETODOLAC IN CLL$0
M01 · FY2002 · RR
ETODOLAC SENSITIZATION OF CLL CELL TO CHEMOTHERAPEUTICS$0
M01 · FY2002 · RR
ETODOLAC SENSITIZATION OF CLL CELL TO CHEMOTHERAPEUTICS$0
M01 · FY2002 · RR
ETODOLAC SENSITIZATION OF CLL CELL TO CHEMOTHERAPEUTICS$0
M01 · FY2002 · RR
ETODOLAC SENSITIZATION OF CLL CELL TO CHEMOTHERAPEUTICS$0
M01 · FY2002 · RR
MOLECULAR THERAPEUTICS OF RHEUMATOID ARTHRITIS$1,098,930
P50 · FY2001 · AR
REGULATION OF SENESCENCE AND APOPTOSIS IN LYMPHOCYTES$267,520
R01 · FY2001 · GM
ROLE OF IMMUNOSTIMULATORY (ISS) DNA IN RHEUMATOID ARTHRITIS$150,001
P50 · FY2001 · AR
Third Biennial Arthritis Research Conference$20,000
R13 · FY2001 · AR
PILOT STUDY TO TEST EFFECTIVENESS OF ETODOLAC IN CLL$0
M01 · FY2001 · RR
PILOT STUDY TO TEST EFFECTIVENESS OF ETODOLAC IN CLL$0
M01 · FY2001 · RR
ETODOLAC SENSITIZATION OF CLL CELL TO CHEMOTHERAPEUTICS$0
M01 · FY2001 · RR
ETODOLAC SENSITIZATION OF CLL CELL TO CHEMOTHERAPEUTICS$0
M01 · FY2001 · RR
MOLECULAR THERAPEUTICS OF RHEUMATOID ARTHRITIS$1,074,215
P50 · FY2000 · AR
REGULATION OF SENESCENCE AND APOPTOSIS IN LYMPHOCYTES$244,420
R01 · FY2000 · GM
ROLE OF IMMUNOSTIMULATORY (ISS) DNA IN RHEUMATOID ARTHRITIS$196,912
P50 · FY2000 · AR
ROLE OF IMMUNOSTIMULATORY (ISS) DNA IN RHEUMATOID ARTHRITIS$196,912
P50 · FY2000 · AR
TRAINING IN CLINICAL IMMUNOLOGY$180,285
T32 · FY2000 · AR
MOLECULAR THERAPEUTICS OF RHEUMATOID ARTHRITIS$50,000
P50 · FY2000 · AR
REGULATION OF SENESCENCE AND APOPTOSIS IN LYMPHOCYTES$22,220
R01 · FY2000 · GM
ETODOLAC SENSITIZATION OF CLL CELL TO CHEMOTHERAPEUTICS$0
M01 · FY2000 · RR
PILOT STUDY TO TEST EFFECTIVENESS OF ETODOLAC IN CLL$0
M01 · FY2000 · RR
ETODOLAC SENSITIZATION OF CLL CELL TO CHEMOTHERAPEUTICS$0
M01 · FY2000 · RR
PILOT STUDY TO TEST EFFECTIVENESS OF ETODOLAC IN CLL$0
M01 · FY2000 · RR
PILOT STUDY TO TEST EFFECTIVENESS OF ETODOLAC IN CLL$0
M01 · FY2000 · RR
ETODOLAC SENSITIZATION OF CLL CELL TO CHEMOTHERAPEUTICS$0
M01 · FY2000 · RR